Last reviewed · How we verify
Qizhitongluo Capsule
Qizhitongluo Capsule is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to relieve pain and improve microcirculation.
Qizhitongluo Capsule is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to relieve pain and improve microcirculation. Used for Chest pain and angina pectoris, Headache and migraine, Limb pain and numbness related to poor circulation.
At a glance
| Generic name | Qizhitongluo Capsule |
|---|---|
| Also known as | QZTL group |
| Sponsor | China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal capsule combines multiple traditional Chinese medicinal ingredients believed to invigorate blood flow, dissolve stagnation, and unblock meridians. The formulation is designed to address pain conditions and circulatory dysfunction through mechanisms consistent with Traditional Chinese Medicine theory, though specific molecular targets have not been well-characterized in Western pharmacological terms.
Approved indications
- Chest pain and angina pectoris
- Headache and migraine
- Limb pain and numbness related to poor circulation
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Qizhitongluo Capsule CI brief — competitive landscape report
- Qizhitongluo Capsule updates RSS · CI watch RSS
- China Academy of Chinese Medical Sciences portfolio CI